4.0 based on 8 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Dr. Ruben Niesvizky, MD is a medical oncology doctor who practices in New York, NY. He is 57 years old and has been practicing for 24 years.Read his story
We're trying something new with Top Care Areas.Was it helpful for you?YesNo
Dr. Niesvizky's bio
This content was provided by Dr. Niesvizky "Dr. Niesvizky is Professor of Medicine at Weill Cornell Medical College and at NewYork Presbyterian Hospital/Weill Cornell Medical Center in Manhattan. He also serves as Director of the Multiple Myeloma Center at NewYork Presbyterian Hospital/Weill Cornell Medical Center. After receiving a medical degree from National University of Mexico, Dr. Niesvizky did a research fellowship in cell biology-granulomonopoiesis and an internal medicine residency at the National Institute of Nutrition in Mexico. He then completed fellowships in New York: one (hematology) at Mount Sinai Medical Center and one (hematology/medical oncology) at Memorial Sloan-Kettering Cancer Center. He has written more than 100 articles, editorials, chapters, and abstracts published in journals such as New England Journal of Medicine, Blood and Leukemia & Lymphoma, most recently on topics such as the treatment of myeloma and Waldenstrom's macroglobulinemia. He is the recipient of various grants and awards from the National Cancer Institute and the Leukemia and Lymphoma Society, including a K23 award and three translational research grants. He received the 2007 Investigator Award of the Michael Wolk Heart Foundation. He has been voted by pears as "Best Doctors" in 2013 and appeared in New York Magazine as Hematolgy "Top Doctors" 2014. A frequent lecturer, Dr Niesvizky regularly presents at annual meetings of the American Society of Hematology and the American Society of Clinical Oncology, of which he is also a member. He is an active member of the International Myeloma Working Group which defines standards of research and practice in myeloma. He is an active participant in clinical trials of promising new drugs and medical procedures for the treatment of myeloma, lymphoma, and related hematologic disorders."
This content was provided by Dr. Niesvizky "As the Director of the Multiple Myeloma Center at New York Presbyterian Hospital-Cornell Medical Center, my duties will focus on providing outstanding clinical care and coordinating a world class clinical translational research program. Prestigious investigators have joined forces to create one of the leading centers for myeloma research. I have no doubt that this cooperative effort forms one of the best myeloma research groups on the World.
My 25 years of experience as a myeloma physician has helped me to appreciate how important it is to treat patients in the context of a comprehensive and individualized program. New York Presbyterian Hospital has an outstanding Bone Marrow Transplant Service (a treatment modality often used for myeloma patients), performing more than 100 transplants per year. It has also been rated the best in the world in the fields of cardiology (heart), neurosurgery and nephrology (kidney). The Hospital for Special Surgery, also part of the New York Presbyterian-Weill Cornell system, has an outstanding group of orthopedic surgeons that support a new comprehensive bone disease program. In addition, as part of our continuing search for more effective therapeutic options, we offer multiple clinical trials utilizing promising new drugs and medical procedures for treating myeloma and related hematological disorders.
The ultimate goal is to find the cure for multiple myeloma. The establishment of a free standing Multiple Myeloma Center at New York Presbyterian Hospital Weill Cornell Medical Center is an important step towards the accomplishment of this goal."
Dr. Niesvizky does not have any board certifications listed.
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Anal and Rectal Cancer
Antiphospholipid Syndrome (APS)
Central Nervous System Lymphoma
Chronic Myeloid Leukemia (CML)
Coagulation Disorders (incl. Hemophilia)
Deep Vein Thrombosis (DVT)
Gallbladder and Biliary Tract Cancer
Graft vs Host Disease
Immune Thrombocytopenic Purpura (ITP)
Macroglobulinemia (incl. Waldenstrom's )
Marginal Zone Lymphoma
Peripheral T-Cell Lymphoma
Polycythemia Rubra Vera
Primary Central Nervous System Lymphoma
Primary Hypercoagulable State (incl. Factor V Leiden Disease)